LINERA M 2.5/500 is a combination oral anti-diabetic medication containing Linagliptin (2.5 mg) and Metformin Hydrochloride (500 mg). This fixed-dose combination is designed for the effective management of Type 2 Diabetes Mellitus in adults, particularly when monotherapy is insufficient to control blood glucose levels.
The combination works synergistically to improve glycemic control without causing significant weight gain or hypoglycemia.